Novo Nordisk

🧬 AI profile — grown from 6ic coverage Novo Nordisk is a Danish multinational pharmaceutical corporation specializing in the development and production of life sciences products. Semaglutide, a drug developed by Novo Nordisk, has gained recognition in recent medical breakthroughs for its potential in age-related weight loss as well as its role in slowing biological aging through its aims to revitalize metabolic and endocrine systems.